Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T12:11:21.295Z.
Calculation as of: 2026-10-06T12:11:21.295Z.
Quote observation: 2026-10-05T17:49:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$264.62M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.32M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.30M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.73M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.51M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$260.97M
EV/EBITDA Ratio
N/A
TTM Avg
167.75x
3Y Avg
167.75x
5Y Avg
167.75x
Market Cap
$269.77M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$270.60M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $264.62M | N/A | N/A | N/A | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.32M | N/A | N/A | N/A | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $262.30M | N/A | N/A | N/A | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A | N/A | N/A | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.51M | N/A | N/A | N/A | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.19M | N/A | N/A | N/A | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.97M | N/A | 167.75x | 167.75x | 167.75x |
| Cartesian Growth Corp. Iv (CGCF)vs › | $269.77M | N/A | N/A | N/A | N/A |
| Freedom Metals Acquisition Corp. (FDMM)vs › | $270.60M | N/A | N/A | N/A | N/A |
| First National Corporation (FXNC)vs › | $270.87M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute